Ellen R.  Strahlman net worth and biography

Ellen Strahlman Biography and Net Worth

Director of Altria Group

Dr. Strahlman served as Executive Vice President, Research & Development and Chief Medical Officer of Becton, Dickinson and Company, a leading global medical technology company, from April 2013 until her retirement in January 2018. Before joining Becton, Dickinson and Company, she served as a Senior Advisor to the CEO at GlaxoSmithKline from April 2012 through March 2013, after previously serving as the Senior Vice President and Chief Medical Officer from April 2008 through March 2012. Prior to 2008, Dr. Strahlman held senior executive leadership roles in global product development and commercialization, medical affairs and business development at leading pharmaceutical and medical technology companies including Pfizer, Inc., Novartis AG, Virogen Limited, Bausch & Lomb, Inc. and Merck & Co., Inc. She served as a director of Syncona Limited from 2016 to November 2020, having previously served as a director of Syncona Partners, LLP.

Dr. Strahlman is a member of the Audit, Innovation and Nominating, Corporate Governance and Social Responsibility Committees.

What is Ellen R. Strahlman's net worth?

The estimated net worth of Ellen R. Strahlman is at least $3.27 million as of September 29th, 2023. Dr. Strahlman owns 75,113 shares of Altria Group stock worth more than $3,270,420 as of April 26th. This net worth estimate does not reflect any other investments that Dr. Strahlman may own. Learn More about Ellen R. Strahlman's net worth.

How do I contact Ellen R. Strahlman?

The corporate mailing address for Dr. Strahlman and other Altria Group executives is 6601 WEST BROAD STREET, RICHMOND VA, 23230. Altria Group can also be reached via phone at (804) 274-2200. Learn More on Ellen R. Strahlman's contact information.

Has Ellen R. Strahlman been buying or selling shares of Altria Group?

Ellen R. Strahlman has not been actively trading shares of Altria Group over the course of the past ninety days. Learn More on Ellen R. Strahlman's trading history.

Who are Altria Group's active insiders?

Altria Group's insider roster includes Martin Barrington (CEO), Jody Begley (SVP), Robert Davis (Director), James Dillard, III (SVP), William Gifford, Jr. (CEO & Director ), Salvatore Mancuso (Exec. VP & CFO ), Brian Quigley (CEO), Ellen Strahlman (Director), W. Surgner, Jr. (VP), and Charles Whitaker (SVP). Learn More on Altria Group's active insiders.

Are insiders buying or selling shares of Altria Group?

In the last twelve months, Altria Group insiders bought shares 1 times. They purchased a total of 1,200 shares worth more than $48,600.00. The most recent insider tranaction occured on November, 6th when Director Robert Matthews Davis bought 1,200 shares worth more than $48,600.00. Insiders at Altria Group own 0.1% of the company. Learn More about insider trades at Altria Group.

Information on this page was last updated on 11/6/2023.

Ellen R. Strahlman Insider Trading History at Altria Group

See Full Table

Ellen R. Strahlman Buying and Selling Activity at Altria Group

This chart shows Ellen R. Strahlman's buying and selling at Altria Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Altria Group Company Overview

Altria Group logo
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $43.37
Low: $43.19
High: $43.94

50 Day Range

MA: $42.12
Low: $39.73
High: $44.94

2 Week Range

Now: $43.37
Low: $39.06
High: $48.04

Volume

10,802,904 shs

Average Volume

11,974,475 shs

Market Capitalization

$74.49 billion

P/E Ratio

9.49

Dividend Yield

9.13%

Beta

0.65